Recombinant adiponectin inhibits proliferation of breast cancer cell lines (MDA-MB-231 and MCF-7) in vitro[11], [12], suggesting that adiponectin may act as a cytokine which can directly suppress tumor growth in vivo. Here, ADIPOQ is linked to neoplasm.